Taking pioglitazone with alcohol may affect blood glucose levels in patients with diabetes.

Triglimicure 2 mg/500 mg/15 mg Tablet may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

Triglimicure 2 mg/500 mg/15 mg Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.Monitor the breastfed baby’s blood sugar during treatment with Triglimicure 2 mg/500 mg/15 mg Tablet

Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.

Triglimicure 2 mg/500 mg/15 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Triglimicure 2 mg/500 mg/15 mg Tablet may be needed. Please consult your doctor.Use of Triglimicure 2 mg/500 mg/15 mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Triglimicure 2 mg/500 mg/15 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Triglimicure 2 mg/500 mg/15 mg Tablet may be needed. Please consult your doctor.Use of Triglimicure 2 mg/500 mg/15 mg Tablet is not recommended in patients with severe liver disease.